Kathleen Borthwick
Fortuna: 31 170 $ al 31/05/2026
Fortuna: 31 170 $ al 31/05/2026
Kathleen Borthwick is currently Chief Financial Officer at Passage Bio, Inc. since 2024.
Formerly, Ms. Borthwick was Head-Business Development at Johnson & Johnson Services, Inc. Education includes an MBA from Tuck School of Business at Dartmouth and an undergraduate degree from The Wharton School of the University of Pennsylvania.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PASSAGE BIO, INC. 0,17 % | 16/03/2026 | 5.402 ( 0,17 % ) | 31 170 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PASSAGE BIO, INC. | Director Financiero/CFO | 28/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company | Health Technology |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.